Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Current Priorities in Health Research Agendas: Tensions Between Public and Commercial Interests in Prioritizing Biomedical, Social, and Environmental Aspects of Health
Predominant health research agendas, usually in line with existing financial incentives for obtaining lucrative research results, tend to focus on therapeutic and pharmacological intervention, prioritizing innovative therapies based on molecular biology and biotechnology approaches. However, commercial interests do not necessarily agree with existing public health priorities. The prevalence of health and biomedical research agendas often neglect not only the less lucrative diseases but also the study of the social and environmental determinants of health and disease, even when addressing these aspects could significantly improve population health at much lower costs. Some examples of absent studies in the health research agendas are the analysis of non-medical factors influencing health outcomes (social determinants of health), the analysis of the relationship between people and their environment (environmental health), or the evaluation of the socio-environmental factors that influence the deterioration of bodies and territories (such as the One Health approach).
New Insights in Leprosy (Hansen's Disease)
Leprosy (or Hansen’s disease) is a chronic infectious granulomatous disease caused by Mycobacterium leprae and Mycobacterium lepromatosis that affects predominantly the skin and peripheral nerves. Leprosy is one of the oldest known illnesses of mankind; however, it is still one of the most neglected diseases worldwide, impacting more than 120 countries, mainly in underdeveloped settings. Early diagnosis and treatment are crucial for reducing the burden of this disease and avoiding long-term irreversible consequences such as deformities and mutilations. Thus, the World Health Organization has focused its efforts on preventive programs as well as the search for easy-to-handle diagnosis tools and the implementation of new strategies to improve the therapeutic options available.
Toxoplasmosis
Scientific motivation to publish this book comes from the increased interest in the study of toxoplasmosis, showed all over the world. Though the Toxoplasma gondii infection was first discovered in 1908, toxoplasmosis remains a today's research topic, a realm of questions and dilemmas that interest both the veterinarians and the human doctors. Studies in the field are directed to the epidemiology of the disease, the sources of infection, epidemiological chains, being underlined the important feature in the transmission of this parasite: the ability to pass from one intermediate host to another intermediate host without passing through the final host - felids. An increased prevalence of toxop...
Middle Range Theory for Nursing
Three-time recipient of the AJN Book of the Year Award! Praise for the third edition: “This is an outstanding edition of this book. It has great relevance for learning about, developing, and using middle range theories. It is very user friendly, yet scholarly." Score: 90, 4 Stars -Doody's Medical Reviews The fourth edition of this invaluable publication on middle range theory in nursing reflects the most current theoretical advances in the field. With two additional chapters, new content incorporates exemplars that bridge middle range theory to advanced nursing practice and research. Additional content for DNP and PhD programs includes two new theories: Bureaucratic Caring and Self-Care of...
Melanoma
This text serves as a very useful clinical guide and realistic approach to the clinical management of melanoma. Primary care physicians, specialists from varying areas of medical practice and numerous other healthcare providers will find this text to be quite useful as a standard daily reference and use in the office setting. It provides a clear and concise source of information in order to make real-life, evidence-based decisions for all aspects of management for cutaneous melanoma. This book also provides the latest breakthroughs in melanoma research, ranging from recent discoveries in genomics and epigenetics, to newly identified genes that have been selectively targeted for the development of a personalized approach to treatment. All chapters are written by specialists and true experts within their respective fields, incorporating the latest scientific, clinical and evidence-based medicine for melanoma (and non-melanoma skin cancers). This up-to-date information can be easily applied and translated to the clinical setting for the melanoma patient.
